Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference147 articles.
1. Eculizumab and beyond: the past, present, and future of complement therapeutics;Patriquin;Transfus Med Rev,2019
2. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases;Schwartz;Nat Rev Drug Discov,2017
3. Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis;Benamu;Curr Opin Infect Dis,2016
4. Applying complement therapeutics to rare diseases;Reis;Clin Immunol,2015
5. Complement in thrombotic microangiopathies: unraveling Ariadne’s thread into the labyrinth of complement therapeutics;Gavriilaki;Front Immunol,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The complement system: A key player in the host response to infections;European Journal of Immunology;2024-08-27
2. The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer;Heliyon;2023-05
3. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment;Frontiers in Oncology;2022-09-13
4. Overview of Myasthenia Gravis Subgroups and its influence on Pregnancy and their Treatment Advances;Pharmacophore;2022
5. Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019;Drug Safety;2021-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3